| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 6+ Months |
| Number of Subjects | 101 |
| Sex | Both Genders |
| Age Range | 18-29, 30-44, 45-64 |
| Body Types | Average |
101 patients suffering from non-psychotic anxiety using Kava (WS 1490 extract) over 25 weeks noted statistically significant benefits starting after week 8.
